by Randy E. Miller | Sep 18, 2024 | FDA, FOIA, Hedge Funds, Medical Devices
FOIAengine: FDA Inspections Prompt FOIA Requests When CEO Quentin Blackford of iRhythm Technologies, Inc. (NASDAQ: IRTC) began his earnings call on August 1, his wearable heart monitor technology company had survived five years of market ups and downs and had...
by Randy E. Miller | Aug 21, 2024 | Antitrust, Cryptocurrency, FOIA, FTC, News Media
FOIAengine Analysis Reveals Targets and Topics News media outlets continued to be the leading submitters of Freedom of Information Act requests to the Federal Trade Commission during the first half of 2024, with many of the requests focused on the agency’s...
by Randy E. Miller | Jul 24, 2024 | FOIA, FTC, Medical Devices, Pharmaceuticals
FOIAengine Reveals Inquiries About FTC’s Inner Workings With the Federal Trade Commission reportedly preparing to sue the three largest pharmacy benefit managers, or PBMs, over their approach to negotiating the availability and prices for drugs, we’re taking a look...
by Randy E. Miller | Jul 3, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals
FOIAengine: Law Firm’s 48 Inquiries Follow Earlier Requests Personal injury law firm Morgan & Morgan continued to push the Food and Drug Administration during May for documents that could strengthen potential litigation challenging popular weight control drugs. ...
by Randy E. Miller | Jun 27, 2024 | FDA, FOIA, SEC
FOIAengine Reveals Trends Behind the Big Numbers at FDA, SEC This week we analyze the sources of Freedom of Information Act requests made during May to the Food and Drug Administration and the Securities and Exchange Commission. This analysis provides a macro view...
